GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 197 filers reported holding GENMAB A/S in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $657,821 | -90.9% | 18,651 | -90.2% | 0.00% | -100.0% |
| Q2 2023 | $7,264,205 | -6.0% | 191,113 | -6.7% | 0.00% | -33.3% |
| Q1 2023 | $7,731,209 | +1206.0% | 204,746 | +1363.8% | 0.00% | – |
| Q4 2022 | $591,975 | -2.0% | 13,987 | -24.8% | 0.00% | – |
| Q3 2022 | $604,000 | -80.4% | 18,604 | -75.7% | 0.00% | -100.0% |
| Q4 2021 | $3,076,000 | -62.2% | 76,424 | -58.9% | 0.00% | -50.0% |
| Q3 2021 | $8,130,000 | +343.8% | 185,906 | +233.9% | 0.00% | +100.0% |
| Q1 2021 | $1,832,000 | +182.3% | 55,672 | +210.5% | 0.00% | – |
| Q3 2020 | $649,000 | -82.5% | 17,928 | -90.2% | 0.00% | -100.0% |
| Q3 2019 | $3,714,000 | – | 182,955 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |